News & Media

Displaying 21 - 40 of 44
January 14, 2014

The Center for Nanomedicine has received a generous donation from the Djernaes Telos Foundation of Santa Barbara. This gift recognizes Christina A. Djernaes who passed away December 20, 2012 after a battle with cancer. CNM Co-Founders Erkki Ruoslahti and Jamey Marth met with Christina after her diagnosis and spoke at length on new technologies and treatments involving nanomediciine that may ultimately provide a cure. It is with sadness and disappointment that Drs. Marth and Ruoslahti learned of Christina’s passing in 2012. “The battle to conquer cancer will continue, it is inevitable that we will win.” said Dr. Marth. “The courage, spirit and generosity of people such as Christina guide us and motivate us to work harder and to never give up. Today, as we remember Christina, we extend out best wishes to her family and friends, and express our thanks to the Djernaes Telos Foundation for their support of us in our search for a cure.”

November 26, 2013

Sepsis, the body’s response to severe infections, kills more people than breast cancer, prostate cancer and HIV/AIDS combined. On average, 30 percent of those diagnosed with sepsis die.

January 30, 2013

Erkki Ruoslahti, M.D., Ph.D., co-founder of the CNM, and his laboratory have published a groundbreaking study in which they have designed a novel peptide capable of penetrating tumors for therapeutic treatment. A major problem in the treatment of cancer is getting anti-cancer drugs both to the site of the tumor and in contact with all cancer cells of the tumor. Their results recently published show that a tumor-specific tissue-penetrating peptide can be constructed de novo from known sequence elements. This principle may be useful in designing tissue-penetrating peptides for cancer and other diseases.

January 04, 2013

While legions of medical researchers have been looking to understand the genetic basis of disease and how mutations may affect human health, a group of biomedical researchers at UC Santa Barbara is studying the metabolism of cells and their surrounding tissue, to ferret out ways in which certain diseases begin. This approach, which includes computer modeling, can be applied to Type 2 diabetes, autoimmune diseases, and neurodegenerative diseases, among others.

September 19, 2012

Thomson Reuters’ annual predictions of who’ll win a Nobel Prize this year includes two cancer researchers, Tony Hunter at the Salk Institute and Erkki Ruoslahti of the Sanford-Burnham Medical Research Institute.

March 27, 2012

KEY News and Dr. Marth discuss how the passage of Proposition 29 would revive cancer research in California, and lead to breakthroughs in treatment and cures. Read more about this on keyt.com.

March 27, 2012

Dr. Ruoslahti is scheduled to give a lecture discussing his research on the use of targeted nanoparticles in cancer diagnosis and treatment.

March 27, 2012

Dr. Marth believes the passage of Prop 29 would be a game changer for medical researchers pursuing treatments and cures for cancer. Visit the Pacific Coast Business Times to read their informational article: “New cigarette tax could be breath of fresh air for cancer researchers.”

February 02, 2012

The Hearst Foundations have awarded Sanford-Burnham Medical Research Institute (Sanford-Burnham) with a grant to advance research in the Institute’s Center for Nanomedicine (CNM), led by Director Jamey Marth, Ph.D.

October 05, 2011

Sanford Burnham Prebys and Salk Institute scientists combine tumor-targeting peptides and nanoparticles to eliminate glioblastoma in a previously untreatable mouse model.

August 15, 2011

High levels of fat shut down a key enzyme that promotes glucose sensing in pancreatic beta cells—revealing a pathway to diabetes.

July 19, 2011

Check out Quentin Hardy’s blog from Forbes Magazine entitled “Big Data’s People-Changing Machine.”

July 05, 2011

Dr. JoAnn Kuchera-Morin, creator and director of the AlloSphere at UC Santa Barbara, recently shared her thoughts on the promise of this 4D technology for medical research.

June 14, 2011

Click here to view the “Champions of Health Care” feature of Dr. Jamey Marth in the Pacific Coast Business Times.

May 18, 2011

A recent article in the Orlando Sentinel and the Los Angeles Times described nanomedicine as one of several technologies that will revolutionize medicine in the coming decade. Dr. Jamey Marth is highlighted in the article.

January 11, 2011

A group of Goleta city officials, led by Mayor Margaret Connell, toured the Center last week. Read about their experience in Noozhawk.

January 11, 2011

TED has earned a reputation as a meeting of the minds, where the brightest of the bright share their light with the curious, the cultured, and the cool. Biomedical researcher Dr. Jamey Marth, director of the Center for Nanomedicine took his place on TED’s elite roster on October 10 (or 10/10/10).

 

VIDEO HERE

 

In case you’re not familiar with the TED phenomenon, it began as a convention showcasing speakers from the worlds of technology, entertainment and design. The 15-minute presentations, known as TED Talks, then took off on the web, reaching millions who could never have attended the convention. Topics range from “Are Mushrooms the New Plastic?” to “What Physics Taught Me About Marketing.” Talks have also included performances by world class musicians and demonstrations of jaw-dropping technology. TED Talks have become extremely popular on the internet, and TED has branched out to allow interested parties to present their own local events under the name TEDx.

TEDx American Riviera, as the Santa Barbara event is known, focused on imagination. Dr. Marth’s imagination has led him to develop nano-sized “smart devices” which diagnose, target, treat and cure disease before it can cause symptoms and spread. This technology could lead to revolutionary treatments for diabetes, Parkinson’s, and Alzheimer’s disease, to name a few.

Pages